237 related articles for article (PubMed ID: 25874545)
1. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
[TBL] [Abstract][Full Text] [Related]
2. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
[TBL] [Abstract][Full Text] [Related]
3. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon.
Noeske J; Voelz N; Fon E; Abena Foe JL
BMC Res Notes; 2012 Mar; 5():160. PubMed ID: 22436423
[TBL] [Abstract][Full Text] [Related]
4. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
[TBL] [Abstract][Full Text] [Related]
5. Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment.
Coronel J; Roper MH; Herrera C; Bonilla C; Jave O; Gianella C; Sabogal I; Huancaré V; Leo E; Tyas A; Mendoza-Ticona A; Caviedes L; Moore DA
Clin Microbiol Infect; 2014 Jun; 20(6):536-41. PubMed ID: 24107197
[TBL] [Abstract][Full Text] [Related]
6. Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis.
Thai PVK; Ha DTM; Hanh NT; Day J; Dunstan S; Nhu NTQ; Kiet VS; Lan NH; Dung NH; Lan NTN; Thuong NT; Lan NN; Liễu PTT; Hồng NT; Điệp ĐC; Thanh NTK; Hội NV; Nghĩa NV; Đại TN; Minh HQ; Thơm NV; Farrar J; Caws M
BMC Infect Dis; 2018 Mar; 18(1):112. PubMed ID: 29510687
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
8. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
[TBL] [Abstract][Full Text] [Related]
9. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
[TBL] [Abstract][Full Text] [Related]
11. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
[TBL] [Abstract][Full Text] [Related]
12. Survey of tuberculosis drug resistance among Tibetan refugees in India.
Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
[TBL] [Abstract][Full Text] [Related]
13. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
14. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana.
Tembo BP; Malangu NG
BMC Infect Dis; 2019 Sep; 19(1):779. PubMed ID: 31492099
[TBL] [Abstract][Full Text] [Related]
16. Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India.
Isaakidis P; Das M; Kumar AM; Peskett C; Khetarpal M; Bamne A; Adsul B; Manglani M; Sachdeva KS; Parmar M; Kanchar A; Rewari BB; Deshpande A; Rodrigues C; Shetty A; Rebello L; Saranchuk P
PLoS One; 2014; 9(10):e110461. PubMed ID: 25333696
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
[TBL] [Abstract][Full Text] [Related]
18. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
[TBL] [Abstract][Full Text] [Related]
19. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
[TBL] [Abstract][Full Text] [Related]
20. Use of drug-susceptibility testing for management of drug-resistant tuberculosis, Thailand, 2004-2008.
Lam E; Nateniyom S; Whitehead S; Anuwatnonthakate A; Monkongdee P; Kanphukiew A; Inyaphong J; Sitti W; Chiengsorn N; Moolphate S; Kavinum S; Suriyon N; Limsomboon P; Danyutapolchai J; Sinthuwattanawibool C; Podewils LJ
Emerg Infect Dis; 2014 Mar; 20(3):400-8. PubMed ID: 24565738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
